熱門資訊> 正文

Satellos Bioscience GAAP每股收益为-1.70美元

2026-03-27 19:06

Satellos Bioscience Inc(MSLE) 0

Satellos Bioscience press release (MSLE): FY GAAP EPS of -$1.70.
Satellos had cash and cash equivalents and short-term investments of $27.7 million as of Dec. 31, 2025, compared with $48.5 million on Dec. 31, 2024. The decrease primarily reflects cash used to fund ongoing operations, particularly clinical trial costs and supporting operating activities.

More on Satellos Bioscience Inc.

Satellos prices $50M public offering
Satellos launches public offering, applies for Nasdaq listing
Historical earnings data for Satellos Bioscience Inc.
Financial information for Satellos Bioscience Inc.

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。